Drug intelligence / Profile preview

Candistat

Development stage
Unknown
Lead developer
Unilab
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Candistat is a brand name for a line of azole antifungal medications, primarily encompassing formulations of **itraconazole** and **miconazole**. As a systemic treatment, the itraconazole capsule formulation is utilized for a variety of fungal infections, including blastomycosis, histoplasmosis, aspergillosis, and onychomycosis. It functions by inhibiting the fungal cytochrome P450-dependent enzyme 14α-demethylase (encoded by the CYP51A1 gene), which is critical for the biosynthesis of ergosterol. The resulting depletion of ergosterol and accumulation of methylated sterol precursors lead to the disruption of fungal cell membrane structure and function. Additionally, Candistat is marketed as a topical cream containing miconazole for the treatment of superficial fungal skin infections. The brand is primarily distributed in specific international markets, such as the Philippines, by manufacturers like Unilab.

Brand names
CandistatCandiaStat
02

Targets

CYP51A1 (Sterol 14α-demethylase)

Beyond the preview

Go deeper on Candistat.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Candistat.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call